Global Retinal Drugs Market 2023-2027

Description

List of Tables

Technavio has been monitoring the retinal drugs market and is forecast to grow by $7275.79 mn during 2022-2027, accelerating at a CAGR of 6.27% during the forecast period. Our report on the retinal drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in prevalence of retinal diseases, emergence of advanced diagnostic tools, and patient assistance programs.

Technavio's retinal drugs market is segmented as below:

By Distribution Channel

Hospital pharmacy
Retail pharmacy
Online pharmacy

By Indication

Macular degeneration
Diabetic eye disease
Others

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the development of innovative therapies as one of the prime reasons driving the retinal drugs market growth during the next few years. Also, rise in demand for sustained-release ocular formulations and advances in diagnostic techniques will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the retinal drugs market covers the following areas:

Retinal drugs market sizing
Retinal drugs market forecast
Retinal drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading retinal drugs market vendors that include Bayer AG, AbbVie Inc., Alcon Inc., Alimera Sciences Inc., Bausch Health Co Inc., Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., Kubota Corp., MeiraGTx Holdings Plc, Novartis AG, Ocular Therapeutix Inc., Oxurion NV, Pfizer Inc., Regeneron Pharmaceuticals Inc., REGENXBIO Inc, Sanofi SA, Santen Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Visufarma, and Johnson and Johnson Services Inc. Also, the retinal drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR70326

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Indication
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global retinal drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global retinal drugs market 2017 - 2021 ($ million)
4.2 Ditribution channel Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Ditribution channel Segment 2017 - 2021 ($ million)
4.3 Indication Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Indication Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel

6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Hospital pharmacy - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
6.4 Retail pharmacy - Market size and forecast 2022-2027
Exhibit 38: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
6.5 Online pharmacy - Market size and forecast 2022-2027
Exhibit 42: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 46: Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Indication

7.1 Market segments
Exhibit 47: Chart on Indication - Market share 2022-2027 (%)
Exhibit 48: Data Table on Indication - Market share 2022-2027 (%)
7.2 Comparison by Indication
Exhibit 49: Chart on Comparison by Indication
Exhibit 50: Data Table on Comparison by Indication
7.3 Macular degeneration - Market size and forecast 2022-2027
Exhibit 51: Chart on Macular degeneration - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Macular degeneration - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Macular degeneration - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Macular degeneration - Year-over-year growth 2022-2027 (%)
7.4 Diabetic eye disease - Market size and forecast 2022-2027
Exhibit 55: Chart on Diabetic eye disease - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Diabetic eye disease - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Diabetic eye disease - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Diabetic eye disease - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 59: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Indication
Exhibit 63: Market opportunity by Indication ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 65: Chart on Market share by geography 2022-2027 (%)
Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 67: Chart on Geographic comparison
Exhibit 68: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Spain - Market size and forecast 2022-2027
Exhibit 97: Chart on Spain - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Spain - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Spain - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Spain - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 105: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 106: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 108: Overview on factors of disruption
11.4 Industry risks
Exhibit 109: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 110: Vendors covered
12.2 Market positioning of vendors
Exhibit 111: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 112: AbbVie Inc. - Overview
Exhibit 113: AbbVie Inc. - Product / Service
Exhibit 114: AbbVie Inc. - Key news
Exhibit 115: AbbVie Inc. - Key offerings
12.4 Alcon Inc.
Exhibit 116: Alcon Inc. - Overview
Exhibit 117: Alcon Inc. - Business segments
Exhibit 118: Alcon Inc. - Key offerings
Exhibit 119: Alcon Inc. - Segment focus
12.5 Alimera Sciences Inc.
Exhibit 120: Alimera Sciences Inc. - Overview
Exhibit 121: Alimera Sciences Inc. - Product / Service
Exhibit 122: Alimera Sciences Inc. - Key offerings
12.6 Bausch Health Co Inc.
Exhibit 123: Bausch Health Co Inc. - Overview
Exhibit 124: Bausch Health Co Inc. - Business segments
Exhibit 125: Bausch Health Co Inc. - Key news
Exhibit 126: Bausch Health Co Inc. - Key offerings
Exhibit 127: Bausch Health Co Inc. - Segment focus
12.7 Bayer AG
Exhibit 128: Bayer AG - Overview
Exhibit 129: Bayer AG - Business segments
Exhibit 130: Bayer AG - Key news
Exhibit 131: Bayer AG - Key offerings
Exhibit 132: Bayer AG - Segment focus
12.8 Bristol Myers Squibb Co.
Exhibit 133: Bristol Myers Squibb Co. - Overview
Exhibit 134: Bristol Myers Squibb Co. - Product / Service
Exhibit 135: Bristol Myers Squibb Co. - Key news
Exhibit 136: Bristol Myers Squibb Co. - Key offerings
12.9 F. Hoffmann La Roche Ltd.
Exhibit 137: F. Hoffmann La Roche Ltd. - Overview
Exhibit 138: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 139: F. Hoffmann La Roche Ltd. - Key news
Exhibit 140: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 141: F. Hoffmann La Roche Ltd. - Segment focus
12.10 Johnson and Johnson Services Inc.
Exhibit 142: Johnson and Johnson Services Inc. - Overview
Exhibit 143: Johnson and Johnson Services Inc. - Business segments
Exhibit 144: Johnson and Johnson Services Inc. - Key news
Exhibit 145: Johnson and Johnson Services Inc. - Key offerings
Exhibit 146: Johnson and Johnson Services Inc. - Segment focus
12.11 MeiraGTx Holdings Plc
Exhibit 147: MeiraGTx Holdings Plc - Overview
Exhibit 148: MeiraGTx Holdings Plc - Product / Service
Exhibit 149: MeiraGTx Holdings Plc - Key offerings
12.12 Novartis AG
Exhibit 150: Novartis AG - Overview
Exhibit 151: Novartis AG - Business segments
Exhibit 152: Novartis AG - Key offerings
Exhibit 153: Novartis AG - Segment focus
12.13 Ocular Therapeutix Inc.
Exhibit 154: Ocular Therapeutix Inc. - Overview
Exhibit 155: Ocular Therapeutix Inc. - Product / Service
Exhibit 156: Ocular Therapeutix Inc. - Key offerings
12.14 Oxurion NV
Exhibit 157: Oxurion NV - Overview
Exhibit 158: Oxurion NV - Product / Service
Exhibit 159: Oxurion NV - Key offerings
12.15 Pfizer Inc.
Exhibit 160: Pfizer Inc. - Overview
Exhibit 161: Pfizer Inc. - Product / Service
Exhibit 162: Pfizer Inc. - Key news
Exhibit 163: Pfizer Inc. - Key offerings
12.16 Regeneron Pharmaceuticals Inc.
Exhibit 164: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 165: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 166: Regeneron Pharmaceuticals Inc. - Key offerings
12.17 Sanofi SA
Exhibit 167: Sanofi SA - Overview
Exhibit 168: Sanofi SA - Business segments
Exhibit 169: Sanofi SA - Key news
Exhibit 170: Sanofi SA - Key offerings
Exhibit 171: Sanofi SA - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 172: Inclusions checklist
Exhibit 173: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 174: Currency conversion rates for US$
13.4 Research methodology
Exhibit 175: Research methodology
Exhibit 176: Validation techniques employed for market sizing
Exhibit 177: Information sources
13.5 List of abbreviations
Exhibit 178: List of abbreviations